✨ Medicines Act Notices
4100 NEW ZEALAND GAZETTE No. 173
Copies of the New Zealand Food Standard 1996 and its amendments are available for purchase from any Bennetts Government Bookshop. Copies of the AFSC and its amendments are available from Information Australia, 75 Flinders Lane, Melbourne VIC 3000, Australia. Telephone 0061 3 9654 2800. Facsimile 0061 3 9650 5261.
Amendment No. 16 to the New Zealand Food Standard 1996, will come into force on the 28th day after the date of this notification.
go8423
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Carboplatin for Injection.
Active Ingredient(s): Carboplatin 10 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Laboratoires Thissen SA, Braine-L’Alleud, Belgium.
Product: Clexane H P.
Active Ingredient(s): Heparin sodium 150 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Rhone-Poulenc Rorer New Zealand Limited.
Manufacturer(s): Rhone-Poulenc Rorer Pharma Specialties, Maisons-Alfort, France.
Product: Fluox.
Active Ingredient(s): Fluoxetine hydrochloride 22.36 mg equivalent to 20 mg fluoxetine.
Dosage Form: Capsule.
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia.
Product: Marcain with Fentanyl Epidural Infusion.
Active Ingredient(s): Bupivacaine hydrochloride (monohydrate) 1.25 mg/mL.
Fentanyl citrate 3.14 µg/mL equivalent to 2 µg/mL Fentanyl.
Dosage Form: Solution for infusion.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.
Product: Marcain with Fentanyl Epidural Infusion.
Active Ingredient(s): Bupivacaine hydrochloride (monohydrate) 1.25 mg/mL.
Fentanyl citrate 7.9 µg/mL equivalent to 5 µg/mL fentanyl.
Dosage Form: Solution for infusion.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.
Product: Mitoxantrone.
Active Ingredient(s): Mitoxantrone hydrochloride 2.328 mg/mL equivalent to 2 mg/mL mitoxantrone free base.
Dosage Form: Concentrate for injection.
NZ Sponsor: Pharmacia & Upjohn.
Manufacturer(s): Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia.
Dated this 10th day of November 1999.
S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go8422
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 173
NZLII —
NZ Gazette 1999, No 173
✨ LLM interpretation of page content
🏥 New Zealand Food Standard 1996, Amendment No. 16
🏥 Health & Social WelfareFood Standard, Amendment, Food Act 1981
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare10 November 1999
Medicines Act 1981, New Medicine, Distribution Consent, Pharmaceuticals
- S. S. Jessamine, Acting Chief Advisor, Safety and Regulation